Results 151 to 160 of about 20,561 (202)

Adverse Events of the BCG (Bacillus Calmette-Guérin) and Rotavirus Vaccines in a Young Infant with Inborn Error of Immunity. [PDF]

open access: yesCase Reports Immunol, 2020
Al-Hammadi S   +7 more
europepmc   +1 more source

Impact of rotavirus vaccines on rotavirus disease

open access: yesExpert Review of Anti-Infective Therapy, 2012
Rotaviruses are the most common cause of acute gastroenteritis in young children worldwide. Both licensed rotavirus vaccines (Rotarix™ [RV1] and RotaTeq™ [RV5]) are effective and safe. Studies from countries that have included RV1 or RV5 in the national immunization programs have demonstrated their safety and sustained efficacy under real-life ...
Philippe Lepage
exaly   +5 more sources

Rotavirus vaccines: recent developments and future considerations

open access: yesNature Reviews Microbiology, 2007
Q1Revisión529-539Two new vaccines have recently been shown to be safe and effective in protecting young children against severe rotavirus gastroenteritis. Although both vaccines are now marketed worldwide, it is likely that improvements to these vaccines
Juana Angel   +2 more
exaly   +2 more sources

New insights into rotavirus vaccines

open access: yesHuman Vaccines and Immunotherapeutics, 2012
Rotavirus vaccines have shown to be effective and well tolerated in clinical trials. However it's crucial to point out that immunization occurs in "real-word" conditions different from ideal clinical trial settings. Thus, the impact of rotavirus vaccines
Chiara Mameli   +2 more
exaly   +2 more sources

Rotavirus vaccines

Current Opinion in Infectious Diseases, 2000
The past few years have seen important developments in understanding the epidemiological and virological characteristics of rotaviruses, and rapid progress has been made in rotavirus vaccine development, but further challenges remain before a vaccine is introduced into widespread use.
Maureen, Lynch   +3 more
openaire   +2 more sources

The rotavirus vaccine

Current Opinion in Pediatrics, 1999
A rotavirus vaccine was recently licensed by the Food and Drug Administration and is likely to be recommended for use in all infants by both the Advisory Committee on Immunization Practices and the American Academy of Pediatrics. If used as recommended, the vaccine is likely to prevent much of the 500,000 physician visits, 50,000 hospitalizations, and ...
P A, Offit, H F, Clark
openaire   +2 more sources

Home - About - Disclaimer - Privacy